Predictors of survival after hepatic resection among patients with colorectal liver metastasis

British Journal of Cancer

Volumn 97, Issue 12, 2007, Pages 1606-1612

  Wang, X ^a   Hershman, D L ^a,b,c   Abrams, J A ^a,b   Feingold, D ^a   Grann, V R ^a,b,c   Jacobson, J S ^b,c   Neugut, A I ^a,b,c,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia University Medical Center ^*  (United States)

^c NONE   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

Colorectal cancer; Elderly; Hepatic resection; Metastases; SEER Medicare

Indexed keywords

FLOXURIDINE; FLUOROURACIL;

AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; ONCOLOGY SERVICE, HOSPITAL; SURVIVAL RATE;

EID: 37048999333     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604093     Document Type: Article

References (43)

1. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238: 871-883; discussion 883-884
2. Asahara T, Kikkawa M, Okajima M, Ojima Y, Toyota K, Nakahara H, Katayama K, Itamoto T, Marubayashi S, One E, Yahata H, Dohi K, Azuma K, Ito K (1998) Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepatogastroenterology 45: 805-811
3. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL (2002) Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40: IV-19-25
4. Begg CB, Cramer LD, Hoskins WJ, Brennan MF (1998) Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280: 1747-1751
5. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346: 1128-1137
6. Blumgart LH, Fong Y (1995) Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 32: 333-421
7. Bolton JS, Fuhrman GM (2000) Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 231: 743-751
8. Cady B, Monson DO, Swinton NW (1970) Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131: 697-700
9. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas Jr RG (1986) Assessing illness severity: does clinical judgment work? J Chronic Dis 39: 439-452
10. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759-766
11. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL (2002) Use of SEER-Medicare data for measuring cancer surgery. Med Care 40: IV-43-48
12. Cummings LC, Payes JD, Cooper GS (2007) Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109: 718-726
13. de Santibanes E, Lassalle FB, McCormack L, Pekolj J, Quintana GO, Vaccaro C, Benati M (2002) Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes. J Am Coll Surg 195: 196-202
14. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619
15. Dimick JB, Cowan Jr JA, Knol JA, Upchurch Jr GR (2003) Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 138: 185-191
16. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321
17. Foster JH (1978) Survival after liver resection for secondary tumors. Am J Surg 135: 389-394
18. Gillams AR, Lees WR (2005) Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 30: 419-426
19. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP (2006) Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol 32: 557-563
20. Hodgson DC, Fuchs CS, Ayanian JZ (2001) Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 93: 501-515
21. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson III AB (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 20: 1499-1505
22. Kemeny NE, Gonen M (2005) Hepatic arterial infusion after liver resection. N Engl J Med 352: 734-735
23. Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53: 1258-1267
24. Klabunde CN, Warren JL, Legler JM (2002) Assessing comorbidity using claims data: an overview. Med Care 40: IV-26-35
25. Longley DB, Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205: 275-292
26. Lorenz M, Muller HH (2000) Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion vs fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18: 243-254
27. Lorenz M, Muller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, Encke A (1998) Randomized trial of surgery vs surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228: 756-762
28. Lygidakis NJ, Ziras N, Parissis J (1995) Resection vs resection combined with adjuvant pre- and post-operative chemotherapy - immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 42: 155-161
29. Minagawa M, Yamamoto J, Miwa S, Sakamoto Y, Kokudo N, Kosuge T, Miyagawa S, Makuuchi M (2006) Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg 141: 1006-1012; discussion 1013
30. Nordlinger B, Collette L, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein W, Walpole E, Gruenberger T (2007) Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I, 25
31. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
32. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, Bugat R, Lazorthes F, Bedenne L (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24: 4976-4982
33. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG (1993) Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31: 732-748
34. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77: 1241-1246
35. Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19: 59-71
36. Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB (2000) Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 284: 3028-3035
37. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343: 1405-1410
38. Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Makuuchi M (2001) Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy. Surgery 129: 408-413
39. Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N (2000) Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: a randomized study. Cancer 88: 1549-1556
40. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB (2002) Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40: IV-55-61
41. Wilson SM, Adson MA (1976) Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111: 330-334
42. Yoshida S, Hazama S, Kondo H, Sakamoto K, Tamesa T, Ueno T, Oka M (2006) Adjuvant hepatic arterial infusion after resection of hepatic metastasis from colorectal cancer. Gan To Kagaku Ryoho 33: 1845-1847
43. Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A, Curley SA, Mentha G, Capussotti L, Vauthey JN (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10: 86-94